Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFMIAcute Kidney Injury Treatment Market Driven by Robust Growth of Dialysis Centers; Set for US$ 3.6 Bn Valuation by 2029

Acute Kidney Injury Treatment Market Driven by Robust Growth of Dialysis Centers; Set for US$ 3.6 Bn Valuation by 2029

Market players are focusing on technology expansion to attain a competitive edge. How the Rise in Geriatric Population is Driving Growth of Acute Kidney Injury Market: New Report Analyzes

Future Market Insights, Dubai: FMI states in its recent study on the acute kidney injury treatment that the market will record a noteworthy CAGR of 8% through 2029. Demand for acute kidney injury is anticipated to continue surging particularly due to the increased global burden of acute kidney injury among people.

hospitals are likely to strengthen their grip on market revenue in the near term, as governments in numerous countries are developing various platforms by creating more treatment options.” says the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-9399

Acute kidney injury Market – Important Highlights

  • According to injury type, the pre-renal injury segment is expected to dominate the acute kidney injury treatment market, owing to its more prevalence in patients with acute kidney injury.
  • By distribution channel, hospitals are anticipated to hold their dominance during the forecasted years
  • Tech-driven AKI treatment devices to gain traction due to their ability to deliver enhanced care and support
  • North America led by the US is estimated to hold the major market share, due to its advancement in technologies and major government investment in the healthcare section.

Acute kidney injury Market – Drivers

  • Rising awareness about health benefits and advancements in diagnostic technology and more product availability is likely to drive the market during the forecast period.
  • An increase in the global geriatric population will drive the market, as older people are prone to health complications.
  • Favorable government policies and guidelines around the world to invest more in healthcare sectors are encouraging market growth.

 

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-9399

 

Acute kidney injury Market – Restraints

  • Lack of early detection of the diseases and limited knowledge among people about kidney health is one of the key restraints.
  • Dialysis is a very costly process, which is followed by long hospital stays which created a financial burden for many people.

COVID-19 Impact on Acute kidney injury Market

The acute kidney injury market growth is expected to be hampered owing to the unprecedented COVID-19 pandemic. As several countries went into lockdown, frequent visits to the hospital got reduced by the patients and the main focus of the doctors shifted to bring this pandemic under control. However, the market is expected to experience a swift turnaround with the stabilization of the economy.

Competitive Landscape

The acute kidney injury market players are leaning towards the expansion of the production facilities besides opting for strategic collaborations to attain a competitive edge.

A few of the key companies functioning in the global market include Braun Melsungen, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Baxter International, Inc.

To have a deeper understanding of the market, you can purchase the report at https://www.futuremarketinsights.com/checkout/9399

About the Study

The study offers readers a comprehensive assessment of the acute kidney injury market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on product type (Dialysis, Drug Therapy, and others), injury(Pre-renal Injury, Intrinsic Renal Injury), distribution channel, and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

 

Explore FMI’s Coverage of the healthcare Industry

Pharmaceutical intermediates market: Get insights on the pharmaceutical intermediates market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2020-2030.

Autoclave Market: FMI’s exhaustive study on the autoclaves market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

Microbial Therapeutic Products Market: Obtain detailed analysis on the microbial therapeutic products market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

 

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centres in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/acute-kidney-injury-treatment-market

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy